News from anivive lifesciences inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Jan 09, 2023, 08:30 ET Anivive Announces Former Latham & Watkins LLP Office Managing Partner Jim Beaubien to their Board of Directors

Anivive Lifesciences, a technology-driven pet pharmaceutical company, announced today the appointment of Jim Beaubien, former Latham and Watkins...

Dec 22, 2022, 13:38 ET Anivive Wins Best Animal Health Company by S&P Global's Head of Animal Health

Anivive named Best Animal Health Company of 2022 by S&P Global's Head of Animal Health for its annual North America award. Animal Health Connect by...

Nov 16, 2022, 14:16 ET Anivive Sponsors National Academy of Sciences Valley Fever Workshop

Anivive Lifesciences, a technology-driven pet pharmaceutical company currently in late-stage development on the commercialization of a Canine Valley...

Jan 12, 2022, 15:56 ET Anivive Licenses Novel Canine Cancer Therapeutic to Expand Sales and Accelerate Pipeline

Anivive Lifesciences, a pet health technology company dedicated to solving unmet needs in the veterinary community, announces that Dechra...

Jul 23, 2021, 14:00 ET Anivive's GC376 Reduces COVID-19 Replication, Shows Potential as New Post-Infection Treatment

The Proceedings of the National Academy of Sciences, one of the world's most cited and comprehensive scientific journals, has released a research...

Jul 08, 2021, 20:44 ET Anivive Awarded $500,000 Grant by the FDA for Canine Cancer Studies

Anivive, a pet health technology company transforming the therapeutic discovery and development process, received $500,000 in grant funding to...

Jul 07, 2021, 13:00 ET Anivive Announces Publication Highlighting the First Successful Use of Artificial Intelligence in Diagnosing Valley Fever in Dogs

Anivive, a pet health technology company transforming the therapeutic discovery and development process, announced the publication of "Detecting...

Jun 28, 2021, 17:57 ET Anivive Expands Specialty Sales Team to Support Rapid National Distribution of LAVERDIA™-CA1 (verdinexor)

To meet demand and help veterinarians incorporate a novel treatment for canine lymphoma, Anivive has expanded its specialty sales team to increase...

Jun 17, 2021, 19:44 ET Anivive Announces Positive Study Results for Antifungal Vaccine to Prevent Canine Valley Fever

Anivive, a pet health technology company transforming the therapeutic discovery and development process, today announced positive results from a...

Jun 03, 2021, 22:54 ET Anivive Highlighted in Scientific American Article on Breakthrough Fungal Vaccine

Anivive's initiative to develop a vaccine against canine Valley Fever is gaining attention as the threat of systemic fungal diseases escalates...

May 26, 2021, 11:16 ET Anivive Announces Collaboration with MWI Animal Health to Provide Veterinarians with the Newest Lymphoma Treatment for Dogs

Anivive, a pharmaceutical startup that uses artificial intelligence (AI)-powered software to develop novel therapeutics for pets, today announced a...

Jan 21, 2021, 13:16 ET Anivive Announces FDA Conditional Approval of LAVERDIA™-CA1 (verdinexor) - the First and Only Oral Tablet to Treat Lymphoma in Dogs

Anivive, a pharmaceutical startup using software to develop novel therapeutics for pets, is delighted to announce that its first commercial product,...

Jul 01, 2020, 18:33 ET Anivive Initiates Two Pre-Clinical Studies of Investigational Antiviral GC376 for the Treatment of COVID-19

Anivive Lifesciences, a biotechnology company focused on developing first-in-class therapies, today announced the initiation of two pre-clinical...

May 26, 2020, 18:36 ET Anivive Repurposes Veterinary Drug GC376 for COVID-19 And Submits Pre-IND to FDA

Anivive Lifesciences, a biotechnology company focused on developing first-in-class therapeutics for veterinary patients, has filed a...